vimarsana.com

Page 398 - கடுமையானது எடுப்போசை சுவாச நோய்க்குறி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research surveys hygiene practices in food supply chains during COVID-19 pandemic

Research surveys hygiene practices in food supply chains during COVID-19 pandemic With the onset of the coronavirus disease 2019 (COVID-19) pandemic, many worried they could be exposed to its causative pathogen – severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – through their food. While more research has suggested transmission through food contamination is unlikely, it has highlighted a need to investigate hygiene and safety practices in food supply chains. Research led by Igor Tomasevic of the University of Belgrade in Siberia found that food safety was not compromised with restrictive hygiene procedures implemented during the pandemic. This study provides an important insight into the response of food safety systems during the first months of the pandemic, elevating the perspective of preventing Covid-19 within conventional food safety management systems,” wrote the research team.

Ethos Laboratories launches high-throughput SARS-CoV-2 variant assay to monitor emerging coronavirus mutations

Press release content from PR Newswire. The AP news staff was not involved in its creation. Ethos Laboratories launches high-throughput SARS-CoV-2 variant assay to monitor emerging coronavirus mutations. April 5, 2021 GMT Ethos Laboratories (PRNewsfoto/Ethos Laboratories) NEWPORT, Ky., April 5, 2021 /PRNewswire/ Ethos Laboratories®, a national leader in laboratory testing, has announced the validation of a high-throughput molecular test for the detection of key SARS-CoV-2 virus strains, including the UK (B.1.1.7), South Africa (B.1.351), Brazil (P.1) variants. These variants have been estimated to account for 40 percent of new infections in certain areas of the United States, making their accurate detection critical for ongoing public health strategies. Ethos is one of the first clinical laboratories to validate a high-throughput testing solution for the detection of emerging SARS-CoV-2 variants.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.